JP2016506775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506775A5 JP2016506775A5 JP2015552868A JP2015552868A JP2016506775A5 JP 2016506775 A5 JP2016506775 A5 JP 2016506775A5 JP 2015552868 A JP2015552868 A JP 2015552868A JP 2015552868 A JP2015552868 A JP 2015552868A JP 2016506775 A5 JP2016506775 A5 JP 2016506775A5
- Authority
- JP
- Japan
- Prior art keywords
- controller
- insulin
- subject
- model
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 16
- 102000004877 Insulin Human genes 0.000 claims description 8
- 108090001061 Insulin Proteins 0.000 claims description 8
- 229940125396 insulin Drugs 0.000 claims description 8
- 210000000496 pancreas Anatomy 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 5
- 239000008103 glucose Substances 0.000 claims 5
- 239000008280 blood Substances 0.000 claims 4
- 210000004369 blood Anatomy 0.000 claims 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 208000013016 Hypoglycemia Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 230000002218 hypoglycaemic effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000001019 normoglycemic effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018228853A JP6914907B2 (ja) | 2013-01-14 | 2018-12-06 | Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361751941P | 2013-01-14 | 2013-01-14 | |
| US61/751,941 | 2013-01-14 | ||
| PCT/US2014/011360 WO2014110538A1 (en) | 2013-01-14 | 2014-01-13 | Model-based personalization scheme of an artificial pancreas for type i diabetes applications |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018228853A Division JP6914907B2 (ja) | 2013-01-14 | 2018-12-06 | Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016506775A JP2016506775A (ja) | 2016-03-07 |
| JP2016506775A5 true JP2016506775A5 (https=) | 2018-05-24 |
Family
ID=51167293
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015552868A Withdrawn JP2016506775A (ja) | 2013-01-14 | 2014-01-13 | Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム |
| JP2018228853A Active JP6914907B2 (ja) | 2013-01-14 | 2018-12-06 | Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018228853A Active JP6914907B2 (ja) | 2013-01-14 | 2018-12-06 | Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10413664B2 (https=) |
| EP (1) | EP2943149B1 (https=) |
| JP (2) | JP2016506775A (https=) |
| KR (1) | KR102211352B1 (https=) |
| AU (1) | AU2014205120B2 (https=) |
| CA (1) | CA2897189C (https=) |
| WO (2) | WO2014109898A1 (https=) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8417311B2 (en) | 2008-09-12 | 2013-04-09 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| WO2009049252A1 (en) | 2007-10-10 | 2009-04-16 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
| US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
| US9292010B2 (en) * | 2012-11-05 | 2016-03-22 | Rockwell Automation Technologies, Inc. | Online integration of model-based optimization and model-less control |
| WO2014109898A1 (en) * | 2013-01-14 | 2014-07-17 | The Regents Of University Of California | Model-based personalization scheme of an artificial pancreas for type i diabetes applications |
| US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
| GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
| CN104749954B (zh) * | 2015-02-08 | 2017-04-12 | 北京化工大学 | 基于内模控制策略的智能灰箱控制系统装置及控制方法 |
| CN111905188B (zh) | 2015-02-18 | 2022-07-22 | 英赛罗公司 | 流体输送和输注装置及其使用方法 |
| US10275573B2 (en) | 2016-01-13 | 2019-04-30 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
| US10806859B2 (en) | 2016-01-14 | 2020-10-20 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
| HK1256995A1 (zh) | 2016-01-14 | 2019-10-11 | Bigfoot Biomedical, Inc. | 药物输送设备、系统和方法中的阻塞解决方案 |
| US12383166B2 (en) | 2016-05-23 | 2025-08-12 | Insulet Corporation | Insulin delivery system and methods with risk-based set points |
| WO2018058041A1 (en) | 2016-09-23 | 2018-03-29 | Insulet Corporation | Fluid delivery device with sensor |
| CA3037432A1 (en) | 2016-12-12 | 2018-06-21 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
| US10500334B2 (en) | 2017-01-13 | 2019-12-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10758675B2 (en) | 2017-01-13 | 2020-09-01 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP3568860B1 (en) | 2017-01-13 | 2025-12-10 | Insulet Corporation | Insulin delivery methods, systems and devices |
| US10583250B2 (en) | 2017-01-13 | 2020-03-10 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
| EP4708311A2 (en) | 2017-01-13 | 2026-03-11 | Insulet Corporation | Insulin delivery methods, systems and devices |
| EP3398558A1 (en) | 2017-05-02 | 2018-11-07 | Carlo Andretta | In body perfusion system |
| CA3198598A1 (en) | 2017-05-05 | 2018-11-08 | Eli Lilly And Company | Closed loop control of physiological glucose |
| EP3438858A1 (en) | 2017-08-02 | 2019-02-06 | Diabeloop | Closed-loop blood glucose control systems and methods |
| WO2019125932A1 (en) | 2017-12-21 | 2019-06-27 | Eli Lilly And Company | Closed loop control of physiological glucose |
| USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
| EP3788628B1 (en) | 2018-05-04 | 2024-12-11 | Insulet Corporation | Safety constraints for a control algorithm-based drug delivery system |
| US12562251B1 (en) | 2018-05-09 | 2026-02-24 | Bigfoot Biomedical, Inc. | Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices |
| CN112313754A (zh) | 2018-06-22 | 2021-02-02 | 伊莱利利公司 | 胰岛素和普兰林肽输送系统、方法和设备 |
| US11147922B2 (en) * | 2018-07-13 | 2021-10-19 | Iowa State University Research Foundation, Inc. | Feedback predictive control approach for processes with time delay in the manipulated variable |
| CN109116738B (zh) * | 2018-09-27 | 2021-04-13 | 杭州电子科技大学 | 一种工业加热炉的二自由度内模控制分析方法 |
| US11628251B2 (en) | 2018-09-28 | 2023-04-18 | Insulet Corporation | Activity mode for artificial pancreas system |
| EP3864668A1 (en) | 2018-10-11 | 2021-08-18 | Insulet Corporation | Event detection for drug delivery system |
| USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
| KR102788429B1 (ko) | 2019-05-02 | 2025-03-27 | 삼성전자주식회사 | 개인화된 생체 정보 보정 장치 및 방법 |
| US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
| US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
| WO2021113647A1 (en) | 2019-12-06 | 2021-06-10 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
| US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
| JP7512395B2 (ja) | 2020-01-06 | 2024-07-08 | インスレット コーポレイション | 持続する残差に基づく食事および／または運動行為の予測 |
| US12370307B2 (en) | 2020-02-03 | 2025-07-29 | Insulet Corporation | Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device |
| US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
| US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
| US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
| US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
| US12495994B2 (en) | 2020-02-20 | 2025-12-16 | Insulet Corporation | Meal bolus subcategories in model based insulin therapy |
| US11607493B2 (en) | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
| WO2022020197A1 (en) | 2020-07-22 | 2022-01-27 | Insulet Corporation | Open-loop insulin delivery basal parameters based on insulin delivery records |
| US11684716B2 (en) | 2020-07-31 | 2023-06-27 | Insulet Corporation | Techniques to reduce risk of occlusions in drug delivery systems |
| US12569619B2 (en) | 2020-09-21 | 2026-03-10 | Insulet Corporation | Techniques for determining automated insulin delivery dosages |
| WO2022072332A1 (en) | 2020-09-30 | 2022-04-07 | Insulet Corporation | Drug delivery device with integrated optical-based glucose monitor |
| EP4221588A1 (en) | 2020-09-30 | 2023-08-09 | Insulet Corporation | Secure wireless communications between a glucose monitor and other devices |
| CN112398401B (zh) * | 2020-10-29 | 2022-03-29 | 上海大学 | 一种基于参数失配的低开关频率多步模型预测控制方法 |
| US11160925B1 (en) | 2021-01-29 | 2021-11-02 | Insulet Corporation | Automatic drug delivery system for delivery of a GLP-1 therapeutic |
| EP4305636A1 (en) | 2021-03-10 | 2024-01-17 | Insulet Corporation | A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions |
| US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
| US20220331520A1 (en) * | 2021-04-20 | 2022-10-20 | Insulet Corporation | Automatic drug delivery system for individuals with type-2 diabetes |
| US12592306B2 (en) | 2021-04-28 | 2026-03-31 | Insulet Corporation | Devices and methods for initialization of drug delivery devices using measured analyte sensor information |
| US20220351820A1 (en) * | 2021-05-01 | 2022-11-03 | Christopher Richard Wilson | Method for determining glucose-dependent insulin sensitivity factors |
| US12496398B2 (en) | 2021-05-28 | 2025-12-16 | Insulet Corporation | Threshold based automatic glucose control response |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| US12514980B2 (en) | 2021-06-30 | 2026-01-06 | Insulet Corporation | Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase |
| US12521486B2 (en) | 2021-07-16 | 2026-01-13 | Insulet Corporation | Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems |
| WO2023049900A1 (en) | 2021-09-27 | 2023-03-30 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
| WO2023070245A1 (en) * | 2021-10-25 | 2023-05-04 | Medtrum Technologies Inc. | Closed-loop artificial pancreas insulin infusion control system |
| CN116020007B (zh) * | 2021-10-25 | 2025-11-25 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| CN116020006B (zh) * | 2021-10-25 | 2025-12-23 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
| US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
| EP4243030A1 (en) | 2022-03-09 | 2023-09-13 | Insulet Corporation | Adjusting medicament delivery parameters in an open loop medicament delivery mode |
| CN120457493A (zh) | 2023-01-06 | 2025-08-08 | 英赛罗公司 | 自动或手动启动的随餐推注输送及随后的自动安全约束放宽 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7806886B2 (en) * | 1999-06-03 | 2010-10-05 | Medtronic Minimed, Inc. | Apparatus and method for controlling insulin infusion with state variable feedback |
| US6575905B2 (en) * | 2000-09-22 | 2003-06-10 | Knobbe, Lim & Buckingham | Method and apparatus for real-time estimation of physiological parameters |
| AU2001292946A1 (en) * | 2000-09-26 | 2002-04-08 | Advantage 3D Llc | Method and system for generation, storage and distribution of omni-directional object views |
| US6544212B2 (en) * | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
| US8114023B2 (en) * | 2006-07-28 | 2012-02-14 | Legacy Emanuel Hospital & Health Center | Analyte sensing and response system |
| US10173006B2 (en) * | 2007-06-21 | 2019-01-08 | University Of Virginia Patent Foundation | LQG artificial pancreas control system and related method |
| CN102395310A (zh) * | 2009-02-26 | 2012-03-28 | 莫尔研究应用有限公司 | 用于自动监控糖尿病相关治疗的方法以及系统 |
| GR1007310B (el) * | 2009-03-09 | 2011-06-10 | Αχιλλεας Τσουκαλης | Εμφυτευσιμος βιοαισθητηρας με αυτοματη βαθμονομηση |
| AU2010239138B2 (en) * | 2009-04-20 | 2016-01-21 | University Of Technology, Sydney | A method and system for determining a variation in a metabolic function and managing the variation accordingly |
| EP2435962B1 (en) * | 2009-05-29 | 2023-04-19 | University of Virginia Patent Foundation | System coordinator and modular architecture for open-loop and closed-loop control of diabetes |
| US8762070B2 (en) * | 2010-02-11 | 2014-06-24 | Regents Of The University Of California | Systems, devices and methods to deliver biological factors or drugs to a subject |
| US9907909B2 (en) * | 2012-12-20 | 2018-03-06 | Animas Corporation | Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas |
| WO2014109898A1 (en) * | 2013-01-14 | 2014-07-17 | The Regents Of University Of California | Model-based personalization scheme of an artificial pancreas for type i diabetes applications |
-
2013
- 2013-12-22 WO PCT/US2013/077363 patent/WO2014109898A1/en not_active Ceased
-
2014
- 2014-01-13 KR KR1020157021705A patent/KR102211352B1/ko active Active
- 2014-01-13 WO PCT/US2014/011360 patent/WO2014110538A1/en not_active Ceased
- 2014-01-13 CA CA2897189A patent/CA2897189C/en active Active
- 2014-01-13 AU AU2014205120A patent/AU2014205120B2/en active Active
- 2014-01-13 JP JP2015552868A patent/JP2016506775A/ja not_active Withdrawn
- 2014-01-13 EP EP14737937.4A patent/EP2943149B1/en active Active
-
2015
- 2015-07-06 US US14/792,524 patent/US10413664B2/en active Active
-
2018
- 2018-12-06 JP JP2018228853A patent/JP6914907B2/ja active Active
-
2019
- 2019-09-17 US US16/574,076 patent/US11197955B2/en active Active
-
2021
- 2021-12-14 US US17/549,935 patent/US12102796B2/en active Active
-
2024
- 2024-07-15 US US18/773,448 patent/US20240366873A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016506775A5 (https=) | ||
| USRE50075E1 (en) | Glucose level control system with offline control based on preceding periods of online control | |
| Sora et al. | Insulin pumps: review of technological advancement in diabetes management | |
| Allen et al. | Current diabetes technology: striving for the artificial pancreas | |
| Peyser et al. | The artificial pancreas: current status and future prospects in the management of diabetes | |
| Del Favero et al. | Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes | |
| Veiseh et al. | A smart insulin patch | |
| JP6378164B2 (ja) | 血糖制御システム | |
| Kovatchev et al. | The artificial pancreas in 2016: a digital treatment ecosystem for diabetes | |
| EP2967450B1 (en) | System for closed-loop control of an artificial pancreas | |
| Keith-Hynes et al. | The diabetes assistant: a smartphone-based system for real-time control of blood glucose | |
| JP2016504119A5 (https=) | ||
| De Paula et al. | Controlling blood glucose variability under uncertainty using reinforcement learning and Gaussian processes | |
| Bally et al. | Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story | |
| Renard et al. | Closed loop developments to improve glucose control at home | |
| Scaramuzza et al. | Use of the predictive low glucose management (PLGM) algorithm in Italian adolescents with type 1 diabetes: CareLink™ data download in a real-world setting | |
| Lee et al. | Design and in silico evaluation of an intraperitoneal–subcutaneous (IP–SC) artificial pancreas | |
| US11904139B2 (en) | Closed-loop control in steady-state conditions | |
| Fratus et al. | A closed-loop microneedle-integrated physiological model for predictive glycemic management | |
| TW201832788A (zh) | 使用於藥物遞送系統中之具有經改良安全性的音頻投藥 | |
| Taylor et al. | New technologies in insulin delivery | |
| Hernández et al. | High-order sliding-mode control for blood glucose regulation in the presence of uncertain dynamics | |
| Miller | Basic Principles of Automated Insulin Delivery Systems | |
| Doyle | Engineering the artificial pancreas | |
| Iancu et al. | Predictive control of blood glucose in diabetes mellitus patients |